April 2022 Design Pharmaceuticals Closes $5 Million Pre-series A Round to Accelerate Commercialization --Design Pharmaceuticals, a company redesigning small molecule drug discovery, today announced the closing Design Pharmaceuticals’ platform is based on ultrahigh-throughput technologies that biomine drug-like

If your team is designing covalent or tight-binding candidates, these principles reduce surprises and Designing for penetration —balance on/off rates to reach inner tissue, not just peripheries. Watch our new trailers for a preview of expert-led GPCR training designed for scientists and drug hunters Jens Carlsson shares how structure-based design, molecular dynamics, and smart collaboration turn models Kenakin… sorely needed in the field." — DrGPCR University Attendee 🚀 Join now — and learn to design

Innovative design approach emphasizing scientific principles over speculation. GPCR News delivers a toolkit of practical innovations—from drug design strategies that anticipate physiological Terry's Corner – Designing Drugs That Anticipate Physiological Pushback Most GPCR programs don’t fail week’s Terry’s Corner  exposes the unseen physiological “opponents” your molecule faces—and how to design Design smarter inotropes:  Dobutamine’s α-activity harnesses baroreflexes to increase contractility without

GPCR, an ecosystem designed to bring together stakeholders interested in using G-Protein Coupled Receptors GPCR About John Azietaku John Teye Azietaku,PhD is a trained pharmacist, holding a Ph.D. in Drug Discovery committed to leveraging his expertise to enhance healthcare outcomes and contribute to the growth of the pharmaceutical GPCR About Cam Sinh Lu Cam Sinh Lu is a PhD student at Monash Institute of Pharmaceutical Sciences, Monash

Eleonora Comeo, PhD candidate at the University of Nottingham and the Monash Institute of Pharmaceutical Sciences, is developing fluorescent ligands to address that gap directly - tools designed to visualize Comeo is a PhD candidate jointly enrolled at the University of Nottingham and the Monash Institute of Pharmaceutical A trained medicinal chemist and pharmacist, her research focuses on the design and synthesis of fluorescent

Evi Kostenis "Pharmacist by training - PhD in Pharmacology - Postdoc at the NIH with Dr. Pharmacology at 7TM Pharma in Denmark; Full professor, department chair and director of the institute for pharmaceutical